Loading...
Patient Centric Needle-Free Therapies Will Capture Global Markets
AnalystHighTarget's Fair Value
US$14.49
54.0% undervalued intrinsic discount10 Sep
US$6.66
1Y
37.6%7D
11.6%1Y
37.6%7D
11.6%You can edit this narrative until Aug 9 9:29 PM. Then, changes will post as Updates.